�鶹��ý

Skip to main content

Baxter International Inc., Claris Lifesciences Limited, and Arjun Handa, In the Matter of (timeline item) - July 20, 2017

July 20, 2017

Agreement Containing Consent Orders (30.83 KB)

Decision and Order [Redacted Public Version] (178.65 KB)

Order to Maintain Assets (77.76 KB)

Complaint (25.43 KB)

Analysis of Agreement Containing Consent Orders to Aid Public Comment (21.3 KB)

Interim Monitor Agreement (622.29 KB)

PRESS RELEASE: FTC Requires Baxter International and Claris Lifesciences to Divest 2 Types of Pharmaceutical Products as Condition of Baxter Acquiring Injectable Drugs Business from Claris